Humanigen Inc (HGENQ)
0.00
0.00 (0.00%)
USD |
OTCM |
May 13, 16:00
Humanigen Shareholders Equity (Quarterly): -49.72M for March 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2023 | -49.72M |
| December 31, 2022 | -46.76M |
| September 30, 2022 | -52.40M |
| June 30, 2022 | -50.09M |
| March 31, 2022 | -25.05M |
| December 31, 2021 | -23.69M |
| September 30, 2021 | -17.64M |
| June 30, 2021 | 43.70M |
| March 31, 2021 | 17.02M |
| December 31, 2020 | 45.54M |
| September 30, 2020 | 77.27M |
| June 30, 2020 | 31.60M |
| March 31, 2020 | -16.29M |
| December 31, 2019 | -14.32M |
| September 30, 2019 | -12.67M |
| June 30, 2019 | -10.76M |
| March 31, 2019 | -9.551M |
| December 31, 2018 | -8.11M |
| September 30, 2018 | -6.693M |
| June 30, 2018 | -7.069M |
| March 31, 2018 | -5.412M |
| December 31, 2017 | -24.34M |
| September 30, 2017 | -21.58M |
| Date | Value |
|---|---|
| June 30, 2017 | -14.69M |
| March 31, 2017 | -8.869M |
| December 31, 2016 | -4.379M |
| September 30, 2016 | -0.185M |
| June 30, 2016 | 3.997M |
| March 31, 2016 | 0.308M |
| December 31, 2015 | 5.732M |
| September 30, 2015 | 4.138M |
| June 30, 2015 | 10.45M |
| March 31, 2015 | 16.10M |
| December 31, 2014 | 24.61M |
| September 30, 2014 | 33.79M |
| June 30, 2014 | 41.39M |
| March 31, 2014 | 50.67M |
| December 31, 2013 | 60.54M |
| September 30, 2013 | 38.31M |
| June 30, 2013 | 49.11M |
| March 31, 2013 | 60.33M |
| December 31, 2012 | -94.94M |
| September 30, 2012 | 19.13M |
| June 30, 2012 | -75.39M |
| December 31, 2011 | -72.34M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-52.40M
Minimum
Sep 2022
77.27M
Maximum
Sep 2020
-6.516M
Average
-15.30M
Median
Shareholders Equity (Quarterly) Benchmarks
| Item 9 Labs Corp | 52.65M |
| Cantabio Pharmaceuticals Inc | -1.889M |
| Affymax Inc | -- |
| Scopus BioPharma Inc | -9.452M |
| Statera BioPharma Inc | -10.24M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.116M |
| Total Liabilities (Quarterly) | 54.84M |
| Current Ratio | 0.0943 |
| Net Debt Paydown Yield | 29.27% |